UNM:NYE-Unum Group (USD)

EQUITY | Insurance - Life | New York Stock Exchange

Last Closing

USD 53.7

Change

+0.55 (+1.03)%

Market Cap

USD 9.93B

Volume

0.95M

Analyst Target

USD 21.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unum Group provides disability insurance products in the United States and the United Kingdom. It also provides a portfolio of other insurance products, including employer- and employee-paid group benefits, life insurance, and other related services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Insurance - Life

Symbol Name Price(Change) Market Cap
MET MetLife Inc

-1.48 (-2.06%)

USD 53.21B
AFL Aflac Incorporated

-0.12 (-0.14%)

USD 48.11B
MET-PA MetLife Inc Preferred Stock Se..

-0.03 (-0.12%)

USD 46.19B
MFC Manulife Financial Corp

+0.10 (+0.43%)

USD 44.17B
MET-PE MetLife Inc Preferred Stock Se..

-0.27 (-1.14%)

USD 43.27B
PRU Prudential Financial Inc

-0.68 (-0.61%)

USD 39.42B
PUK Prudential Public Limited Comp..

+0.16 (+0.88%)

USD 25.10B
GL Globe Life Inc

+0.21 (+0.28%)

USD 10.94B
PRI Primerica Inc

-5.13 (-2.35%)

USD 7.71B
LNC Lincoln National Corporation

-0.15 (-0.54%)

USD 5.21B

ETFs Containing UNM

FLI:CA CI U.S. & Canada Lifeco C.. 10.82 % 0.92 %

-0.06 (0.66%)

CAD 0.08B
EZM WisdomTree U.S. MidCap Ea.. 0.79 % 0.38 %

+0.22 (+0.66%)

USD 0.77B
DFAT Dimensional U.S. Targeted.. 0.52 % 0.00 %

+0.34 (+0.66%)

USD 9.40B
FNK First Trust Mid Cap Value.. 0.00 % 0.70 %

+0.10 (+0.66%)

USD 0.23B
FXO First Trust Financials Al.. 0.00 % 0.63 %

-0.19 (0.66%)

USD 0.87B
KIE SPDR® S&P Insurance ETF 0.00 % 0.35 %

-0.77 (0.66%)

USD 0.71B
ZEUS:CA 0.00 % 0.73 %

N/A

N/A
USSC:LSE SPDR® MSCI USA Small Cap.. 0.00 % 0.00 %

+0.55 (+0.66%)

USD 0.46B
ZPRV:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+0.74 (+0.66%)

USD 0.50B
ZPRV:XETRA SPDR® MSCI USA Small Cap.. 0.00 % 0.00 %

+0.77 (+0.66%)

USD 0.50B

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.75% 86% B+ 91% A-
Dividend Return 0.81% 44% F 46% F
Total Return 19.56% 86% B+ 91% A-
Trailing 12 Months  
Capital Gain 36.61% 67% D+ 86% B+
Dividend Return 3.63% 44% F 53% F
Total Return 40.23% 67% D+ 86% B+
Trailing 5 Years  
Capital Gain 58.73% 53% F 74% C
Dividend Return 18.21% 62% D 67% D+
Total Return 76.94% 60% D- 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 19.81% 89% A- 85% B
Dividend Return 24.33% 95% A 87% B+
Total Return 4.52% 82% B 79% B-
Risk Return Profile  
Volatility (Standard Deviation) 41.16% 16% F 25% F
Risk Adjusted Return 59.13% 84% B 85% B
Market Capitalization 9.93B 53% F 84% B

Key Financial Ratios

  Ratio vs. Industry/Classification (Insurance - Life) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 11.10 67% 84%
Price/Book Ratio 0.98 71% 71%
Price / Cash Flow Ratio 7.85 28% 46%
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity 13.97% 77% 70%
Return on Invested Capital 9.99% 85% 64%
Return on Assets 1.84% 82% 42%
Debt to Equity Ratio 35.54% 62% 69%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.